Migraine and patent foramen ovale
Related Experiment Video
Updated: May 4, 2026

Closure of a Patent Foramen Ovale PFO: An Intervention Sequence
Published on: December 23, 2022
1Department of Neurology, Georgetown Headache Center, Georgetown University Hospital, 3800 Reservoir Road NW, 7PHC, Washington, DC, USA, Jessica.x.ailani@gunet.georgetown.edu.
Abstract:
Migraine is a widespread disorder with a large impact on society. Patent foramen ovale (PFO) is a common occurrence, affecting about 25 % of the population. Observational studies report PFO to be more prevalent in patients with migraine with aura, and patients with migraine with aura have a higher incidence of PFO. The only population-based study does not support this link. It is possible that an association exists between large-sized PFO and migraine. This association may explain how migraine with aura can be triggered. Numerous studies have reported improved migraine with PFO closure, but the only prospective placebo-controlled trial aimed at closure of PFO in patients with migraine with aura did not support this. At this time, evidence does not support the routine detection and closure of PFO in patients with migraine.
Insights
Patent foramen ovale (PFO) closure is not recommended for migraine patients. Current evidence does not support routine PFO screening or treatment for managing migraine with aura.
Area of Science:
- Neurology
- Cardiology
- Medical Devices
Background:
- Migraine is a prevalent neurological disorder impacting society.
- Patent foramen ovale (PFO) affects approximately 25% of the population.
- Observational studies suggest a link between PFO and migraine with aura, though population-based data is conflicting.
Purpose of the Study:
- To evaluate the association between PFO and migraine, particularly migraine with aura.
- To assess the efficacy of PFO closure in improving migraine symptoms.
Main Methods:
- Review of observational studies reporting PFO prevalence in migraine patients.
- Analysis of prospective, placebo-controlled trials on PFO closure for migraine with aura.
Main Results:
- Observational studies indicate a higher prevalence of PFO in migraine with aura patients.
- The only prospective, placebo-controlled trial did not demonstrate improved migraine outcomes after PFO closure.
- Evidence does not support routine PFO detection or closure for migraine management.
Conclusions:
- Current evidence does not support the routine screening or closure of PFO in patients experiencing migraines.
- The potential association between large PFOs and migraine triggers requires further investigation.
- PFO closure is not currently recommended as a standard treatment for migraine with aura.
Related Concept Videos
Increased Intracranial Pressure ll: Pathophysiology
Mitral Valve Prolapse III: Nursing Management
Mitral Valve Prolapse I: Introduction
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Mitral Stenosis I: Introduction
The Arch of Aorta
Encircling the heart, the coronary arteries form a ring-like structure before...

